America’s Covid-testing infrastructure, from drugstores to diagnostics manufacturers, is bracing for a surge in demand following the Biden administration’s order that most large U.S. companies mandate their workers get vaccinated or be screened weekly for the virus.
Makers of over-the-counter Covid-19 tests are continuing to boost production, while laboratories and companies are ramping up operations that some had scaled back after the virus largely retreated earlier this year.
